Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Laryngoscope. 2016 Jan;126(1):44-50. doi: 10.1002/lary.25507. Epub 2015 Jul 30.

REMODEL larger cohort with long-term outcomes and meta-analysis of standalone balloon dilation studies.

Author information

1
Department of Otolaryngology, Vanderbilt University School of Medicine, Nashville, Tennessee.
2
Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
3
Associates of Otolaryngology, Denver, Colorado, U.S.A.

Abstract

OBJECTIVES/HYPOTHESIS:

To provide the final results from the REMODEL (randomized evaluation of maxillary antrostomy versus ostial dilation efficacy through long-term follow-up) full-study cohorts and perform meta-analyses of standalone balloon sinus dilation studies to explore long-term outcomes in a large patient sample.

STUDY DESIGN:

Randomized controlled trial and meta-analysis.

METHODS:

Final outcomes from the REMODEL randomized trial, including a larger cohort of 135 patients treated with functional endoscopic sinus surgery (FESS) or in-office balloon dilation, were evaluated. One hundred thirty patients had 12-month data, 66 had 18-month data, and 25 had 24-month data. In addition, a meta-analysis evaluated outcomes from six studies including 358 standalone balloon dilation patients with up to 24 months follow-up.

RESULTS:

Outcomes out to 2 years from the REMODEL full-study cohort are consistent with 6-month and 12-month outcomes. In the meta-analysis of standalone balloon dilation studies, technical success is 97.5%, and mean 20-item Sino-Nasal Outcomes Test scores are significantly and clinically improved at all time points (P < .0001). There are significant reductions (P < .0001) in work/school days missed, homebound days, physician/nurse visits, acute infections, and antibiotic prescriptions. Mean recovery time is 1.4 days. Comparison of 12-month symptom improvements and revision rates between the REMODEL FESS arm (n = 59), REMODEL balloon dilation arm (n = 71), and pooled single-arm standalone balloon dilation studies (n = 243) demonstrated no statistical difference.

CONCLUSIONS:

All outcomes are comparable between FESS and balloon dilation at all time points from 6 months to 24 months. Balloon dilation produces faster recovery, less postoperative pain, and fewer debridements than FESS. There is significant, durable benefit in a large series of 358 patients undergoing standalone balloon dilation.

KEYWORDS:

Balloon sinus dilation; chronic rhinosinusitis; endoscopic sinus surgery; long-term outcomes; meta-analysis; randomized controlled trial

PMID:
26228589
PMCID:
PMC5132108
DOI:
10.1002/lary.25507
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center